Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126828061 | 12682806 | 1 | I | 20160812 | 20160825 | 20160825 | EXP | GB-CIPLA LTD.-2016GB17492 | CIPLA | BABIKER ZO, HOGAN C, USTIANOWSKI A, WILKINS E. DOES INTERFERON-SPARING TENOFOVIR DISOPROXIL FUMARATE-BASED THERAPY HAVE A ROLE IN THE MANAGEMENT OF SEVERE ACUTE HEPATITIS DELTA SUPERINFECTION?. JOURNAL OF MEDICAL MICROBIOLOGY. 2012;61:1780 TO 1783 | 0.00 | Y | 0.00000 | 20160825 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126828061 | 12682806 | 1 | PS | Tenofovir | TENOFOVIR | 1 | Unknown | UNK | 78800 | ||||||||||
| 126828061 | 12682806 | 2 | SS | Tenofovir | TENOFOVIR | 1 | 78800 | ||||||||||||
| 126828061 | 12682806 | 3 | SS | LAMIVUDINE. | LAMIVUDINE | 1 | Unknown | UNK | 0 | ||||||||||
| 126828061 | 12682806 | 4 | SS | LAMIVUDINE. | LAMIVUDINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126828061 | 12682806 | 1 | Hepatitis D |
| 126828061 | 12682806 | 2 | Hepatitis B |
| 126828061 | 12682806 | 3 | Hepatitis D |
| 126828061 | 12682806 | 4 | Hepatitis B |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126828061 | 12682806 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126828061 | 12682806 | Gastric ulcer | |
| 126828061 | 12682806 | Treatment noncompliance | |
| 126828061 | 12682806 | Viral load increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |